Molecular determinants of atherosclerotic plaque vulnerability

Annals of the New York Academy of Sciences

Volumn 811, Issue , 1997, Pages 134-145

  Libby, Peter ^a   Geng, Yong Jian ^a   Sukhova, Galina K ^a   Simon, Daniel I ^a   Lee, Richard T ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; GAMMA INTERFERON; MATRIX METALLOPROTEINASE; STROMELYSIN;

APOPTOSIS; ATHEROSCLEROTIC PLAQUE; COLLAGEN SYNTHESIS; CONFERENCE PAPER; EXTRACELLULAR MATRIX; FIBRINOLYSIS; FOAM CELL; HEMODYNAMICS; HUMAN; ISCHEMIC HEART DISEASE; PATHOLOGY; THROMBOSIS; VASCULAR SMOOTH MUSCLE;

EID: 0030793634     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1997.tb51996.x     Document Type: Conference Paper

References (33)

1. DAVIES, M. J. & A. C. THOMAS. 1985. Plaque fissuring - the cause of acute myocardial infarction, sudden ischemic death, and crescendo angina. Br. Heart J. 53: 363-373.
2. FALK, E. 1983. Plaque rupture with severe pre-existing stenosis precipitating coronary thrombosis characteristics of coronary atherosclerotic plaques underlying fatal occlusive thrombi. Br. Heart J. 50: 127-134.
3. CONSTANTINIDES, P. 1989. Plaque hemorrhages, their genesis and their role in supraplaque thrombosis and atherogenesis. In Pathobiology of the Human Atherosclerotic Plaque. S. Glagov, W. P. I. Newman & S. A. Schaffer, Eds.: 393-412. Springer-Verlag. New York.
4. DAVIES, M. J., P. D. RICHARDSON, N. WOOLF, D. R. KATZ & J. MANN. 1993. Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content. Br. Heart J. 69: 377-381.
5. LOREE, H. M., R. D. KAMM, R. G. STRINGFELLOW & R. T. LEE. 1992. Effects of fibrous cap thickness on peak circumferential stress in model atherosclerotic vessels. Circ. Res. 71: 850-858.
6. FALK, E., P. SHAH & V. FUSTER. 1995. Coronary plaque disruption. Circulation 92: 657-671.
7. LENDON, C. L., M. J. DAVIES, G. V. BORN & P. D. RICHARDSON. 1991. Atherosclerotic plaque caps are locally weakened when macrophages density is increased. Atherosclerosis 87: 87-90.
8. CHENG, G. C., H. M. LOREE, R. D. KAMM, M. C. FISHBEIN & R. T. LEE. 1993. Distribution of circumferential stress in ruptured and stable atherosclerotic lesions: a structural analysis with histopathologic correlation. Circulation 87: 1179-1187.
9. MULLER, J. E., G. S. ABELA, R. W. NESTO & G. H. TOFLER. 1994. Triggers, acute risk factors and vulnerable plaques: the lexicon of a new frontier. [Review]. J. Am. Coll. Cardiol. 23: 809-813.
10. LOREE, H. M., B. J. TOBIAS, L. J. GIBSON, R. D. KAMM, D. M. SMALL & R. T. LEE. 1994. Mechanical properties of model atherosclerotic lesion lipid pools. Arterioscler. Thromb. 14: 230-234.
11. LOREE, H. M., A. J. GRODZINSKY, S. Y. PARK, L. J. GIBSON & R. T. LEE. 1994. Static circumferential tangential modulus of human atherosclerotic tissue. J. Biomech. 27: 195-204.
12. AMENTO, E. P., N. EHSANI, H. PALMER & P. LIBBY. 1991. Cytokines positively and negatively regulate intersitial collagen gene expression in human vascular smooth muscle cells. Arteriosclerosis 11: 1223-1230.
13. LIAU, G. & L. M. CHAN. 1989. Regulation of extracellular matrix RNA levels in cultured smooth muscle cells. Relationship to cellular quiescence. J. Biol. Chem. 264: 10315-10320.
14. VAN DER WAL, A. C., A. E. BECKER, C. M. VAN DER LOOS & P. K. DAS. 1994. Site of intimai rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 89: 36-44.
15. REKHTER, M., K. ZHANG, A. NARAYANAN, S. PHAN, M. SCHORK & D. GORDON. 1993. Type I collagen gene expression in human atherosclerosis. Localization to specific plaque regions. Am. J. Pathol. 143: 1634-1648.
16. DOLLERY, C. M., J. R. MCEWAN & A. M. HENNEY. 1995. Matrix metalloproteinases and cardiovascular disease. [Review]. Circ. Res. 77: 863-868.
17. WOESSNER, J. J. 1991. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 5: 2145-2154.
18. MATRISIAN, L. M. 1994. Matrix metalloproteinase gene expression. [Review]. Ann. N. Y. Acad. Sci. 732: 42-50.
19. OKADA, A., J. P. BELLOCQ, N. ROUYER, M. P. CHENARD, M. C. RIO, P. CHAMBON & P. BASSET. 1995. Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas. Proc. Natl. Acad. Sci. USA 92: 2730-2734.
20. HENNEY, A. M., P. R. WAKELEY, M. J. DAVIES, K. FOSTER, R. HEMBRY, G. MURPHY & S. HUMPHRIES. 1991. Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization. Proc. Natl. Acad. Sci. USA 88: 8154-8158.
21. GALIS, Z., G. SUKHOVA, M. LARK & P. LIBBY. 1994. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J. Clin. Invest. 94: 2493-2503.
22. BROWN, D. L., M. S. HIBBS, M. KEARNEY, C. LOUSHIN & J. M. ISNER. 1995. Identification of 92-kD gelatinase in human coronary atherosclerotic lesions. Association of active enzyme synthesis with unstable angina. Circulation 91: 2125-2131.
23. NIKKARI, S. T., K. D. O'BRIEN, M. FERGUSON, T. HATSUKAMI, H. G. WELGUS, C. E. ALPERS & A. W. CLOWES. 1995. Interstitial collagenase (MMP-1) expression in human carotid atherosclerosis. Circulation 92: 1393-1398.
24. GALIS, Z., G. SUKHOVA & P. LIBBY. 1995. Microscopic localization of active proteases by in situ zymography. Detection of matrix metalloproteinase activity in vascular tissue. FASEB J. 9: 974-980.
25. GALIS, Z., G. SUKHOVA, R. KRANZHÖFER, S. CLARK & P. LIBBY. 1995. Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases. Proc. Natl. Acad. Sci. USA 92: 402-406.
26. SUKHOVA, G., D. SIMON, H. CHAPMAN & P. LIBBY. 1995. Cytokines regulate the expression by vascular smooth muscle cells of cathepsin S, an elastase found in human atheroma. J. Invest. Med. 43: 311A.
27. GENG, Y.-J., Q. WU, M. MUSZYNSKI, G. HANSSON & P. LIBBY. 1996. Apoptosis of vascular smooth muscle cells induced by in vitro stimulation with interferon-gamma, tumor necrosis factor-alpha, and interleukin-1-beta. Arterioscler. Thromb. Vascular Biol. 16: 19-27.
28. GENG, Y.-J. & P. LIBBY. 1995. Evidence for apoptosis in advanced human atheroma. Co-localization with interleukin-1 β-converting enzyme. Am. J. Pathol. 147: 251-266.
29. HAN, D., C. HAUDENSCHILD, M. HONG, B. TINKLE, M. LEON & G. LIAU. 1995. Evidence for apoptosis in human atherogenesis and in a rat vascular injury model. Am. J. Pathol. 147: 267-277.
30. BROWN, B. G., X. Q. ZHAO, D. E. SACCO & J. J. ALBERS. 1993. Lipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary disease. [Review]. Circulation 87: 1781-1791.
31. BLANKENHORN, D. H. & H. N. HODIS. 1994. Arterial imaging and atherosclerosis reversal. Arterioscler. Thromb. 14: 177-192.
32. GROUP SSSS. 1994. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandanavian Simvastatin Survival Study (4S). Lancet 344: 1383-1389.
33. SHEPERD, J., S. COBBE, I. FORD, C. ISLES, A. LORIMER, P. MACFARLANE, J. MCKILLOP & C. PACKARD. 1995. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N. Engl. J. Med. 333: 1301-1307.